Axios Pro Rata: Anthropic ahead | Axios Pro Rata Summary

1. Key Themes

Theme: The Nvidia leadership shock is creating contagion risk for the AI trade, with Anthropic's IPO as the most exposed major deal

Anthropic's financial entanglement with Nvidia

Anthropic is simultaneously Nvidia's investment target and its biggest customer, so turmoil at Nvidia hits it from both directions.

"Nvidia agreed to purchase around $10 billion of Anthropic shares via a $26 billion private placement concurrent to the IPO. That ties it with Google for the largest investor in that deal, and is in addition to a $10 billion funding commitment that Nvidia made to Anthropic late last year."

"Anthropic also has committed hundreds of billions of dollars to cloud computing deals for Nvidia GPUs, including with SpaceX, Microsoft, Nscale, and Lambda."

The macro risk is an AI-trade reorientation

"The macro is a possible unwind, or at least reorientation, of the AI trade. The micro is a myriad of financial and strategic ties between the two companies."

Future Nvidia mega-deals are now uncertain

Primack stops short of predicting a default, but flags ambiguity for IPO buyers.

"There is no indication that Nvidia wouldn't make good on any of its pledges, and the Anthropic IPO is said to be oversubscribed (although we don't know at what price), but we're obviously in uncharted territory."

"At the very least, Anthropic IPO investors should view the prospect of future mega-deals with Nvidia as hazy."

Theme: The Nvidia saga is becoming a political and regulatory scandal, not just a business one

Inter-agency conflict over export controls

"Treasury Secretary Scott Bessent on CNBC this morning threw Commerce Secretary Howard Lutnick under the bus, saying that Treasury, State, Defense, and USTR all wanted to put Megaspeed on the restricted entities list 'for months, but Commerce has the pen.'"

Congressional scrutiny is coming

"There are bipartisan calls for Jensen and Lutnick to testify in front of the Senate during its lame duck session, with Lutnick having already agreed. New questions also are being raised as to how certain the U.S. government is that Alice Huang was a spy, and who might have leaked the classified State Department memo to that effect."

"Again, this could become as much a political scandal as a business one."

Market reaction so far is partial

"Nvidia shares opened up about 2% this morning, which would put it close to early Tuesday trading levels — two days before Jensen resigned — and down around 11% from last Friday's open."

Theme: Private capital is becoming a funding source for Big Pharma R&D, inverting the traditional biotech financing model

Blackstone as "biotech bank"

"Blackstone has become something akin to a biotech bank, helping offset drug development costs for Pfizer, Apogee, Alnylam, Boston Scientific, J&J, Merck, and Moderna."

A reversal of historical public/private roles

"It's a reversal of the industry's historical relationship between public and private markets — whereby private investors usually back biotech startups and then sell to Big Pharma once it comes time to run expensive Phase 2/3 clinical trials."

Deal structure and the investor's rationale

"Blackstone's funding commitment runs through 2028, and the firm is eligible for earnouts based on U.S. regulatory approval and commercial sales milestones."

"Pfizer has handed a large part of its obesity research bill to an outside investor .... What [Blackstone] gains is a return stream tied to drug risk, which does not move with buyouts or real estate."

Theme: Japan's M&A boom has cooled only modestly despite a political shift

Still historically elevated

"Japan M&A activity is around $140 billion year-to-date, down 32% from this point in 2025. But that's still blowing away the prior 15 years, only one of which (2020) even breached the $100 billion mark YTD."

Domestic strategic deals drive the decline

"Most of the decline has come domestically and strategically, as cross-border M&A is only down 9% and PE-backed M&A is down 15%."

Theme: Capital continues flowing into AI infrastructure, agents, and healthcare AI at large scale

Frontier labs still raise huge early rounds

"Mirendil, an SF-based frontier lab, raised $1b in Series A funding. Kleiner Perkins and Clearlake Capital led, joined by Battery Ventures, Doerr Capital, Gil & Co, Google, M13, Pear VC, and S32."

Agent tooling is commanding unicorn valuations

"LangChain, an SF-based AI agent engineering platform, raised $300m at a $3b post-money valuation. CapitalG led, joined by GIC, DFJ Growth and insiders IVP and Sapphire Ventures."

"Kindo, an AI agent management platform, raised $30m led by Crosspoint Capital and Forgepoint Capital."

Data center infrastructure is drawing strategic M&A interest

"Samsung Electronics is in talks to acquire Modine Manufacturing (NYSE: MOD), per Bloomberg. Modine is a Racine, Wis.-based maker of cooling systems for data centers with a $5.6b market cap."

2. Contrarian Perspectives

Nvidia's turmoil could benefit closed-model makers

Most would read Huang's departure as purely negative for AI companies tied to Nvidia. Primack notes an offsetting upside for closed-model labs like Anthropic.

"On the upside, Jensen Huang was a very vocal cheerleader for open-source AI, so his ouster could give some boost to closed model makers like Anthropic."

The Nvidia crisis may be more political than commercial

The consensus framing is a corporate governance and AI-demand story; Primack suggests the larger risk may be regulatory and political, with agency infighting, congressional testimony, and a leaked classified memo.

"Again, this could become as much a political scandal as a business one."

Japan's dealmaking has held up better than expected

The question last year was whether a new prime minister would chill M&A. The data suggests a milder effect, and the decline is concentrated in domestic strategic deals rather than cross-border or PE deals.

"The early verdict is that it has, but only slightly."

3. Companies Identified

Anthropic

Description: Closed-model AI lab preparing an IPO.
Why mentioned: The central case study; its IPO is exposed to Nvidia's turmoil through investment and compute ties.
Quote: "Anthropic's IPO is just a week away, and is suddenly trying to dodge Nvidia fallout."

Nvidia

Description: AI chip leader; CEO Jensen Huang resigned, with Colette Kress now interim CEO.
Why mentioned: The source of contagion risk and of regulatory and political scrutiny.
Quote: "Nvidia shares opened up about 2% this morning... and down around 11% from last Friday's open."

Blackstone Life Sciences

Description: Life sciences arm of Blackstone.
Why mentioned: Acting as a "biotech bank," financing Pfizer's GLP-1 development.
Quote: "Blackstone Life Sciences has agreed to pay Pfizer (NYSE: PFE) up to $1.5 billion to finance development of a monthly GLP-1 receptor agonist."

Pfizer

Description: Big Pharma company.
Why mentioned: Offloading obesity R&D costs to compete with Lilly and Novo.
Quote: "It could help Pfizer better compete with Eli Lilly and Novo in the booming weight management market."

Metsera

Description: Obesity drug developer acquired by Pfizer.
Why mentioned: Source of the berobenatide candidate.
Quote: "The investigational drug candidate is called berobenatide, and was acquired by Pfizer via last year's $9.8 billion takeover of Metsera."

Mirendil

Description: SF-based frontier AI lab.
Why mentioned: Raised a $1b Series A.
Quote: "Mirendil, an SF-based frontier lab, raised $1b in Series A funding."

LangChain

Description: AI agent engineering platform.
Why mentioned: $300m raise at a $3b post-money valuation.
Quote: "LangChain, an SF-based AI agent engineering platform, raised $300m at a $3b post-money valuation."

Databento

Description: Finance market data platform.
Why mentioned: $100m Series C at a $1.1b valuation.
Quote: "Databento, a finance market data platform, raised $100m in Series C funding at a $1.1b valuation."

Mount Thor

Description: Managed Apple infrastructure provider for AI research and deployment.
Why mentioned: Raised $45m, a niche infrastructure play.
Quote: "Mount Thor, a Mill Valley, Calif.-based provider of managed Apple infrastructure for AI research and deployment, raised $45m in seed and Series A funding."

Windward Bio Group

Description: Swiss antibody developer, Phase 2/3 biotech.
Why mentioned: Biotech IPO priced mid-range at roughly a $1b value.
Quote: "It priced in the middle of its $16-$18 range for a $1b fully diluted value, and plans to list on the Nasdaq (WWB)."

Modine Manufacturing

Description: Maker of data center cooling systems, $5.6b market cap.
Why mentioned: Potential Samsung acquisition target, signaling data center infrastructure M&A.
Quote: "Samsung Electronics is in talks to acquire Modine Manufacturing (NYSE: MOD), per Bloomberg."

Hancock Whitney / Trustmark

Description: Regional banks.
Why mentioned: $3.2b all-stock bank consolidation deal.
Quote: "Hancock Whitney (Nasdaq: HWC) agreed to buy rival Mississippi bank Trustmark (Nasdaq: TRMK) for $3.2b in stock."

Genesee & Wyoming

Description: Short-line railroad backed by Brookfield and GIC.
Why mentioned: Planned split into three regional companies.
Quote: "Genesee & Wyoming, a short-line railroad backed by Brookfield and GIC, plans to split into three regional companies."

4. People Identified

Jensen Huang

Description: Former Nvidia CEO, who resigned.
Why mentioned: His departure is the catalyst for the AI-trade uncertainty.
Quote: "Jensen Huang was a very vocal cheerleader for open-source AI, so his ouster could give some boost to closed model makers like Anthropic."

Colette Kress

Description: Nvidia interim CEO.
Why mentioned: Reportedly worried about Huang's dealmaking.
Quote: "A new WSJ report suggesting that interim CEO Colette Kress was worried that Jensen ventured out over his skis on certain dealmaking."

Dario Amodei

Description: Anthropic CEO.
Why mentioned: Appearing in a livestreamed conversation with Jamie Dimon the day of the newsletter.
Quote: "Anthropic CEO Dario Amodei has a livestreamed conversation with JPMorgan CEO Jamie Dimon."

Scott Bessent

Description: Treasury Secretary.
Why mentioned: Publicly blamed Commerce for delaying restrictions on Megaspeed.
Quote: "Treasury, State, Defense, and USTR all wanted to put Megaspeed on the restricted entities list 'for months, but Commerce has the pen.'"

Howard Lutnick

Description: Commerce Secretary.
Why mentioned: Target of Bessent's criticism; has agreed to testify to the Senate.
Quote: "There are bipartisan calls for Jensen and Lutnick to testify in front of the Senate during its lame duck session, with Lutnick having already agreed."

Alice Huang

Description: Subject of a leaked classified State Department memo alleging she was a spy.
Why mentioned: Questions are being raised about the government's certainty and the leak.
Quote: "New questions also are being raised as to how certain the U.S. government is that Alice Huang was a spy, and who might have leaked the classified State Department memo to that effect."

Sanae Takaichi

Description: Japan's prime minister.
Why mentioned: Her election prompted questions about the dealmaking boom.
Quote: "Last year we wondered if Japan's election of Sanae Takaichi as prime minister would cool the country's dealmaking boom."

Omor Ibne Ehsan

Description: Writer at 24/7 Wall St.
Why mentioned: Articulated the rationale for Blackstone's Pfizer deal.
Quote: "What [Blackstone] gains is a return stream tied to drug risk, which does not move with buyouts or real estate."

5. Operating Insights

Disentangle supplier, customer, and investor relationships before a major capital event

Anthropic's exposure shows the risk when one counterparty is investor, vendor, and ecosystem partner at once. Operators heading into IPOs or large raises should stress-test what happens if a key counterparty faces leadership or regulatory disruption.

"The macro is a possible unwind, or at least reorientation, of the AI trade. The micro is a myriad of financial and strategic ties between the two companies."

Consider non-dilutive, milestone-based capital to fund expensive late-stage development

Pfizer's deal shows a structure where an incumbent shares development cost and risk in exchange for earnouts. Companies with capital-intensive programs can explore similar structures instead of funding everything from the balance sheet.

"Blackstone's funding commitment runs through 2028, and the firm is eligible for earnouts based on U.S. regulatory approval and commercial sales milestones."

Build for specific underserved infrastructure niches

Mount Thor (managed Apple infrastructure for AI) and Opdo (optical engineering) raised capital by targeting narrow infrastructure needs, suggesting investors will fund focused layers of the AI stack beyond the headline model and chip companies.

"Mount Thor, a Mill Valley, Calif.-based provider of managed Apple infrastructure for AI research and deployment, raised $45m in seed and Series A funding."

6. Overlooked Insights

Genesee & Wyoming's planned three-way split signals a possible unbundling trend in infrastructure assets

Brookfield and GIC backing a split of a short-line railroad into regional companies is a small mention, but it suggests sponsors may unlock value in infrastructure platforms by separating them.

"Genesee & Wyoming, a short-line railroad backed by Brookfield and GIC, plans to split into three regional companies."

Strategic buyers are targeting data center cooling

Samsung's reported interest in Modine points to thermal management as an increasingly strategic layer of AI infrastructure, and a potential M&A theme beyond chips and compute.

"Modine is a Racine, Wis.-based maker of cooling systems for data centers with a $5.6b market cap."